摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(8-amino-1-iodo-imidazo[1,5-a]pyrazin-3-yl)-1-hydroxymethyl-cyclobutanol | 1272668-12-8

中文名称
——
中文别名
——
英文名称
3-(8-amino-1-iodo-imidazo[1,5-a]pyrazin-3-yl)-1-hydroxymethyl-cyclobutanol
英文别名
3-(8-Amino-1-iodoimidazo[1,5-a]pyrazin-3-yl)-1-hydroxycyclobutanemethanol;3-(8-amino-1-iodoimidazo[1,5-a]pyrazin-3-yl)-1-(hydroxymethyl)cyclobutan-1-ol
3-(8-amino-1-iodo-imidazo[1,5-a]pyrazin-3-yl)-1-hydroxymethyl-cyclobutanol化学式
CAS
1272668-12-8
化学式
C11H13IN4O2
mdl
——
分子量
360.154
InChiKey
XYPFOPIMWJEGTM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    96.7
  • 氢给体数:
    3
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] BENZENE-FUSED 6-MEMBERED OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF BICYCLIC HETEROARYLS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES D'HÉTÉROARYLES BICYCLIQUES À 6 CYCLES BENZÉNIQUES ACCOLÉS DE BENZÈNE CONTENANT DE L'OXYGÈNE
    申请人:NOVARTIS AG
    公开号:WO2011064211A1
    公开(公告)日:2011-06-03
    The invention relates to new derivatives of formula I, wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of a proliferative disease.
    这项发明涉及公式I的新衍生物,其中取代基如规范中所定义;制备这种衍生物的方法;包括这种衍生物的药物组合物;这种衍生物作为药物;这种衍生物用于治疗增殖性疾病。
  • ETHER DERIVATIVES OF BICYCLIC HETEROARYLS
    申请人:Chen Bei
    公开号:US20120165310A1
    公开(公告)日:2012-06-28
    The invention relates to compounds of formula I, wherein the substituents are as defined in the specification; to processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; such compounds as a medicament; such compounds for the treatment of a proliferative disease.
    本发明涉及式I的化合物,其中取代基如规范中所定义;制备此类化合物的方法;包含此类化合物的制药组合物;此类化合物作为药物;此类化合物用于治疗增生性疾病。
  • Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
    申请人:Chen Bei
    公开号:US20120289501A1
    公开(公告)日:2012-11-15
    The invention relates to new derivatives of formula I, wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of a proliferative disease.
    本发明涉及I式的新衍生物,其中取代基如规范中定义;制备这种衍生物的方法;包含这种衍生物的药物组合物;这种衍生物作为药物;这种衍生物用于治疗增生性疾病。
  • BENZENE-FUSED 6-MEMBERED OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF BICYCLIC HETEROARYLS
    申请人:Novartis AG
    公开号:EP2504339A1
    公开(公告)日:2012-10-03
查看更多

同类化合物

顺式-3-(8-氨基-1-溴咪唑并[1,5-a]吡嗪-3-基)-1-甲基环丁醇 咪唑并[1,5-a]吡嗪-8-胺 咪唑并[1,5-a]吡嗪-8(7H)-硫酮 咪唑并[1,5-a]吡嗪-3-硫醇 N-(2,6-二甲基苯基)-5-(4-甲氧基苯基)咪唑并[1,5-a]吡嗪-8-胺 N-(2,6-二甲基苯基)-5-(3-甲氧基苯基)咪唑并[1,5-a]吡嗪-8-胺 8-氯咪唑并[1,5-a]吡嗪 8-氯咪唑并[1,5-A]吡嗪-1-甲酸乙酯 8-氯-3-环丁基-1-碘-咪唑并[1,5-a]吡嗪 8-氯-3-异丙基咪唑并[1,5-A]吡嗪 8-氯-1-碘-3-异丙基咪唑并[1,5-A]吡嗪 6-氯咪唑并[1,5-A]吡嗪 5H,10H-二咪唑并[1,5-a:1, 5-d] 吡嗪-5,10-二酮 5-溴-8-氯咪唑并[1,5-a]吡嗪 5-溴-7-(4-甲氧基苄基)咪唑并[1,5-a]吡嗪-8-(7H)-酮 5-(4-甲氧基苯基)-7H-咪唑并[1,5-a]吡嗪-8-酮 5,10-二氧代-5H,10H-二咪唑并[1,5-a:1',5'-d]吡嗪-1,6-二甲酸 3-甲基咪唑并[1,5-a]吡嗪-8(7H)-硫酮 3-甲基咪唑并[1,5-A]吡嗪 3-环己基咪唑并[1,5-a]吡嗪 3-环丁基-1-碘-咪唑并[1,5-a]吡嗪-8-胺 3-(甲硫基)-1-硝基-咪唑并[1,5-a]吡嗪 3-(甲氧基甲基)-咪唑并[1,5-a]吡嗪 3-(叔丁基)-8-氯咪唑并[1,5-a]吡嗪 3-(叔丁基)-8-氯-1-碘咪唑并[1,5-a]吡嗪 3-(三氟甲基)咪唑并[1,5-a]吡嗪 3-(8-BROMO-1-CHLOROH-PYRROLO[1,2-A]PYRAZIN-6-YL)CYCLOBUTANONE无结构图 3-(1-CHLOROH-PYRROLO[1,2-A]PYRAZIN-6-YL)CYCLOBUTANONE无结构图 1-碘-3-异丙基咪唑并[1,5-A]吡嗪-8-胺 1-碘-3-叔丁基咪唑并[1,5-a]吡嗪-8-胺 1-溴-6-氯-咪唑并[1,5-a]吡嗪 1-溴-3-甲基-咪唑并[1,5-a]吡嗪 1-溴-3-(四氢-2H-吡喃-4-基)咪唑并[1,5-a]吡嗪-8-胺 mesityl(8-methoxy-3-methylimidazo[1,5-a]pyrazin-5-yl)methanol 3-ethylsulfanyl-7H-imidazo[1,5-a]pyrazin-8-one;hydrochloride (cis)-4-(1-bromo-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexyl acetate trans-[Ni(mcpa)2(H2O)2] 3-(8-amino-1-iodoimidazo[1,5-a]pyrazin-3-yl)-N-ethyl-N-(2-hydroxyethyl)propanamide 8-amino-3-cyclopropylimidazo[1,5-a]pyrazine-1-carboxylic acid 3-(8-amino-1-iodoimidazo[1,5-a]pyrazin-3-yl)cyclobutanol 2,3-Diamino-5-iodo-3H-pyrimidin-4-one Cyclobutanol, 3-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)-1-methyl-, cis- 1-iodo-3-[3-(4-methyl-piperazin-1-yl)-cyclobutyl]-imidazo[1,5-a]pyrazin-8-ylamine 1-(2-phenylethyl)-6-cyanomethyl-7,8-dibromopyrrolo[1,2-a]pyrazine N-(1-methylethyl)-2-[6-[3-(methyloxy)phenyl]-4-oxo-2-{[3-(1-piperidinyl)propyl]oxy}pyrazolo[1,5-a]pyrazin-5(4H)-yl]acetamide dibromobis(2,5-dimethylpyrazine)zinc(II) N-(((trans)-4-(1-bromo-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexyl)methyl)acetamide 5-chloro-1-iodo-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-8-amine methyl (5R,6R,7S,8S)-8-acetamido-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-2-acetate methyl ((trans)-4-(1-bromo-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexyl)methylcarbamate